Does clozapine promote employability and reduce offending among mentally disordered offenders?

Canadian Journal of Psychiatry

Volumn 55, Issue 1, 2010, Pages 50-56

  Balbuena, Lloyd ^a   Mela, Mansfield ^b   Wong, Stephen ^c   Gu, Deqiang ^d   Adelugba, Olajide ^d   Tempier, Raymond ^b  

^a CARLETON UNIVERSITY   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c INSTITUTE OF MENTAL HEALTH   (United Kingdom)

^d Regional Psychiatric Centre   (Canada)

Author keywords

Antipsychotic; Clozapine; Forensic psychiatry; Institutional employment

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; LEVOMEPROMAZINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CONTROLLED STUDY; EMPLOYABILITY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL PATIENT; OFFENDER; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; TREATMENT DURATION;

EID: 76649091259     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371005500108     Document Type: Article

References (24)

1. Lindstrom LH. Long-term clinical and social outcome studies in schizophrenia in relation to the cognitive and emotional side effects of antipsychotic drugs. Acta Psychiatr Scand Suppl. 1994;380:74-76.
2. Meltzer HY, Burnett S, Bastani B, et al. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry. 1990;41(8):892-897.
3. Chakos M, Lieberman J, Hoffman E, et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry. 2001;158(4):518-526.
4. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45(9):789-796.
5. Masellis M, Basile VS, Meltzer HY, et al. Lack of association between the TC 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. Schizophr Res. 2001;47(1):49-58.
6. Sanger TM, Lieberman JA, Tohen M, et al. Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry. 1999;156(1):79-87.
7. McEvoy JP, Lieberman JA, Stroup TS, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry. 2006;163(4):600-610.
8. Lewis SW, Barnes TR, Davies L, et al. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull. 2006;32(4):715-723.
9. Hodgins S. Mental disorder, intellectual deficiency, and crime. Evidence from a birth cohort. Arch Gen Psychiatry. 1992;49(6):476-483.
10. Swanson JW, Holzer CE 3rd, Ganju VK, et al. Violence and psychiatric disorder in the community: evidence from the Epidemiologic Catchment Area surveys. Hosp Community Psychiatry. 1990;41(7):761-770.
11. Freedman R, Ross R, Michels R, et al. Psychiatrists, mental illness, and violence. Am J Psychiatry. 2007;164(9):1315-1317.
12. Buckley P, Bartell J, Donenwirth K, et al. Violence and schizophrenia: clozapine as a specific antiaggressive agent. Bull Am Acad Psychiatry Law. 1995;23(4):607-611.
13. Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial ( InterSePT). Arch Gen Psychiatry. 2003;60(1):82-91.
14. Kraus JE, Sheitman BB. Clozapine reduces violent behavior in heterogeneous diagnostic groups. J Neuropsychiatry Clin Neurosci. 2005;17(1):36-44.
15. Meltzer HY. Clozapine: is another view valid? Am J Psychiatry. 1995;152(6):821-825.
16. Chow EWC, Bury AS, Roy R, et al. The effect of clozapine on aggression. Abstracts of the 149th annual meeting of the American Psychiatric Association, New York (NY): APA; 1996. p 170.
17. Glazer WM, Dickson RA. Clozapine reduces violence and persistent aggression in schizophrenia. J Clin Psychiatry. 1998;59 Suppl 3:8-14.
18. Frankle W, Shera D, Berger-Hershkowitz H, et al. Clozapine-associated reduction in arrest rates of psychotic patients with criminal histories. Am J Psychiatry. 2001;158(2):270-274.
19. Greenwood A, Burt G. Validity of the Brief Psychiatric Rating Scale within a forensic inpatient hospital. Expert Evid. 2001;8(1):15-30.
20. Volavka J, Czobor P, Nolan K, et al. Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychopharmacol. 2004;24(2):225-228.
21. Young CR, Longhurst JG, Bowers MB Jr, et al. The expanding indications for clozapine. Exp Clin Psychopharmacol. 1997;5(3):216-234.
22. Menditto AA, Beck NC, Stuve P, et al. Effectiveness of clozapine and a social learning program for severely disabled psychiatric inpatients. Psychiatr Serv. 1996;47(1):46-51.
23. Krakowski MI, Czobor P, Citrome L, et al. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 2006;63(6):622-629.
24. Krakowski MI, Czobor P, Nolan KA. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients. J Clin Psychopharmacol. 2008;28(5):485-493.